HADM_ID,ICUSTAY_ID,CHARTTIME,CATEGORY,DESCRIPTION,TEXT,Summary
101091.0,273922,2104-12-14 15:04:00,Physician ,Physician Attending Progress Note,"Chief Complaint: Respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Pt. known to MICU service from 2 prior recent MICU transfers during
   present hospitalization.  Most recently transferred back to medical
   [**Hospital1 **] [**2104-12-12**].
   Currently returns for marked hypoxemia, malaise, significant cough
   (non-productive) and persistent respiratory distress.  Awakened this AM
   with malaise, fatigue but no chest pain.  ABG= 7.46/38/65.  Hypoxemia
   requred increased FIO2 by face mask with good effect.  Scheduled for
   repeat CT angio and transfer back to MICU service for additional
   evaluation and management.
   Upon arrival to MICU, states to feel improved.  Good SaO2 on NC.
   Noted to have new skin rash -- erythematous macular-papular rash over
   trunk/back.  Non-prurutic.
   Denies increased cough, sputum, hemoptysis, chest pain, pleurisy.
   Denies abd pain, back pain.
   History obtained from [**Hospital 31**] Medical records
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever, No(t) Weight loss
   Eyes: No(t)  Blurry vision, No(t) Conjunctival edema
   Ear, Nose, Throat: No(t) Dry mouth, No(t) Epistaxis, No(t) OG / NG tube
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Edema,
   No(t) Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO, No(t) Tube feeds, No(t) Parenteral nutrition
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea, No(t) Wheeze
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   No(t) Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria, Foley, No(t) Dialysis
   Musculoskeletal: No(t) Joint pain, No(t) Myalgias
   Integumentary (skin): No(t) Jaundice, No(t) Rash
   Endocrine: Hyperglycemia, No(t) History of thyroid disease
   Heme / Lymph: No(t) Lymphadenopathy, No(t) Anemia, No(t) Coagulopathy
   Neurologic: No(t) Numbness / tingling, No(t) Headache, No(t) Seizure
   Psychiatric / Sleep: No(t) Agitated, No(t) Suicidal, No(t) Delirious,
   No(t) Daytime somnolence, Appears depressed
   Allergy / Immunology: Immunocompromised, No(t) Influenza vaccine
   Signs or concerns for abuse : No
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2104-12-14**] 03:03 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.6
   HR: 104 (97 - 106) bpm
   BP: 110/66(77) {110/66(77) - 129/78(90)} mmHg
   RR: 14 (14 - 25) insp/min
   SpO2: 93%
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
             35 mL
   PO:
             TF:
   IVF:
   35 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                     35 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No(t) No acute distress, No(t)
   Overweight / Obese, No(t) Thin, No(t) Anxious, No(t) Diaphoretic,
   Chronically ill
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva
   pale, No(t) Sclera edema
   Head, Ears, Nose, Throat: Normocephalic, No(t) Poor dentition, No(t)
   Endotracheal tube, No(t) NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Supraclavicular WNL, No(t) Cervical
   adenopathy
   Cardiovascular: (PMI Normal, No(t) Hyperdynamic), (S1: Normal, No(t)
   Absent), (S2: Normal, No(t) Distant, No(t) Loud, No(t) Widely split ,
   No(t) Fixed), No(t) S3, No(t) S4, No(t) Rub, (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical),
   (Percussion: Resonant : , No(t) Hyperresonant: , No(t) Dullness : ),
   (Breath Sounds: No(t) Clear : , No(t) Crackles : , No(t) Bronchial: ,
   No(t) Wheezes : , No(t) Diminished: , No(t) Absent : , Rhonchorous:
   scattered)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender: , No(t) Obese
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Musculoskeletal: Muscle wasting, Unable to stand
   Skin:  Warm, Rash: macular-papular erythematous rash over trunk, No(t)
   Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, No(t) Oriented (to): , Movement: Purposeful, No(t) Sedated,
   No(t) Paralyzed, Tone: Normal
   Labs / Radiology
   11.9 g/dL
   296 K/uL
   90 mg/dL
   0.9 mg/dL
   26 mEq/L
   4.4 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   34.5 %
   11.4 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   Plt
   [**Telephone/Fax (3) 3174**]03
   296
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   Glucose
   90
   105
   104
   100
   90
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.7 mg/dL, Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Imaging: CT angio with no evidence for PE.  However, interval
   development of multiple densities, LLL >> RLL and mid lung zones.
   Assessment and Plan
   HYPOXEMIA -- attributed to new pneumonia on background of RSV
   infection.   No evidence for pulmonary embolism by today's CT scan.
   Evidence for new pulmonary infiltrates on right and left upper lobes
   --> possibly representing new infection or process (ex. PcP or other
   fungal infection), progression of underlying infection, complication of
   medications (ex. related to rash, related to antibody administration).
   Plan continue supplimental oxygen, monitor RR, maintain SaO2 > 90%,
   continue empirical antimicrobials.  Provide beta-agonist.  Check on
   next scheduled PcP prophylaxis Would check LE NIVS to assess for DVT.
   Check beta-galactomannan.  Consider bronchoscopy, although would
   require intubation to perform procedure safely.  Low threshold for
   intubation in event of clinical decline.
   PNEUMONIA (HAP) -- clinical variability on current regimen.  Doubt OI.
   Consider bronchoscopic investigation.  Continue current level of care.
   Interval development of multiple pulmonary infiltates  may represent
   aspiration or atuypical pneuonia, but may also represent process such
   as right-sided endovascular infeciton (ex. endocarditis, line-related
   infection).  Check blood cultures, consider repeat echo.
   RSV infection -- s/p antibody treatment.
   Cough -- attributed to RSV and HAP.  Improving.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye (CT angio).
   CML s/p SCT c/b GVHD
 continue current level of care.
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with suppliments.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   20 Gauge - [**2104-12-14**] 10:59 AM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: None)
   Stress ulcer: H2 blocker
   VAP: HOB elevation
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: Respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Resident for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   Pt. known to MICU service from 2 prior recent MICU transfers during
   present hospitalization.  Most recently transferred back to medical
   [**Hospital1 **] [**2104-12-12**].
   Currently returns for marked hypoxemia, malaise, significant cough
   (non-productive) and persistent respiratory distress.  Awakened this AM
   with malaise, fatigue but no chest pain.  ABG= 7.46/38/65.  Hypoxemia
   requred increased FIO2 by face mask with good effect.  Scheduled for
   repeat CT angio and transfer back to MICU service for additional
   evaluation and management.
   Upon arrival to MICU, states to feel improved.  Good SaO2 on NC.
   Noted to have new skin rash -- erythematous macular-papular rash over
   trunk/back.  Non-prurutic.
   Denies increased cough, sputum, hemoptysis, chest pain, pleurisy.
   Denies abd pain, back pain.
   History obtained from [**Hospital 31**] Medical records
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Infusions:
   Other ICU medications:
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Constitutional: Fatigue, No(t) Fever, No(t) Weight loss
   Eyes: No(t)  Blurry vision, No(t) Conjunctival edema
   Ear, Nose, Throat: No(t) Dry mouth, No(t) Epistaxis, No(t) OG / NG tube
   Cardiovascular: No(t) Chest pain, No(t) Palpitations, No(t) Edema,
   No(t) Tachycardia, No(t) Orthopnea
   Nutritional Support: NPO, No(t) Tube feeds, No(t) Parenteral nutrition
   Respiratory: No(t) Cough, No(t) Dyspnea, No(t) Tachypnea, No(t) Wheeze
   Gastrointestinal: No(t) Abdominal pain, No(t) Nausea, No(t) Emesis,
   No(t) Diarrhea, No(t) Constipation
   Genitourinary: No(t) Dysuria, Foley, No(t) Dialysis
   Musculoskeletal: No(t) Joint pain, No(t) Myalgias
   Integumentary (skin): No(t) Jaundice, No(t) Rash
   Endocrine: Hyperglycemia, No(t) History of thyroid disease
   Heme / Lymph: No(t) Lymphadenopathy, No(t) Anemia, No(t) Coagulopathy
   Neurologic: No(t) Numbness / tingling, No(t) Headache, No(t) Seizure
   Psychiatric / Sleep: No(t) Agitated, No(t) Suicidal, No(t) Delirious,
   No(t) Daytime somnolence, Appears depressed
   Allergy / Immunology: Immunocompromised, No(t) Influenza vaccine
   Signs or concerns for abuse : No
   Pain: No pain / appears comfortable
   Flowsheet Data as of  [**2104-12-14**] 03:03 PM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.4
C (97.6
   Tcurrent: 36.4
C (97.6
   HR: 104 (97 - 106) bpm
   BP: 110/66(77) {110/66(77) - 129/78(90)} mmHg
   RR: 14 (14 - 25) insp/min
   SpO2: 93%
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
             35 mL
   PO:
             TF:
   IVF:
   35 mL
   Blood products:
   Total out:
                                                                      0 mL
                                                                      0 mL
   Urine:
   NG:
   Stool:
   Drains:
   Balance:
                                                                      0 mL
                                                                     35 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ////
   Physical Examination
   General Appearance: Well nourished, No(t) No acute distress, No(t)
   Overweight / Obese, No(t) Thin, No(t) Anxious, No(t) Diaphoretic,
   Chronically ill
   Eyes / Conjunctiva: PERRL, No(t) Pupils dilated, No(t) Conjunctiva
   pale, No(t) Sclera edema
   Head, Ears, Nose, Throat: Normocephalic, No(t) Poor dentition, No(t)
   Endotracheal tube, No(t) NG tube, No(t) OG tube
   Lymphatic: Cervical WNL, No(t) Supraclavicular WNL, No(t) Cervical
   adenopathy
   Cardiovascular: (PMI Normal, No(t) Hyperdynamic), (S1: Normal, No(t)
   Absent), (S2: Normal, No(t) Distant, No(t) Loud, No(t) Widely split ,
   No(t) Fixed), No(t) S3, No(t) S4, No(t) Rub, (Murmur: Systolic, No(t)
   Diastolic)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric, No(t) Paradoxical),
   (Percussion: Resonant : , No(t) Hyperresonant: , No(t) Dullness : ),
   (Breath Sounds: No(t) Clear : , No(t) Crackles : , No(t) Bronchial: ,
   No(t) Wheezes : , No(t) Diminished: , No(t) Absent : , Rhonchorous:
   scattered)
   Abdominal: Soft, Non-tender, Bowel sounds present, No(t) Distended,
   No(t) Tender: , No(t) Obese
   Extremities: Right: Trace, Left: Trace, No(t) Cyanosis, No(t) Clubbing
   Musculoskeletal: Muscle wasting, Unable to stand
   Skin:  Warm, Rash: macular-papular erythematous rash over trunk, No(t)
   Jaundice
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, No(t) Oriented (to): , Movement: Purposeful, No(t) Sedated,
   No(t) Paralyzed, Tone: Normal
   Labs / Radiology
   11.9 g/dL
   296 K/uL
   90 mg/dL
   0.9 mg/dL
   26 mEq/L
   4.4 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   34.5 %
   11.4 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   Plt
   [**Telephone/Fax (3) 3174**]03
   296
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   Glucose
   90
   105
   104
   100
   90
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.7 mg/dL, Mg++:2.3 mg/dL, PO4:2.7 mg/dL
   Imaging: CT angio with no evidence for PE.  However, interval
   development of multiple densities, LLL >> RLL and mid lung zones.
   Assessment and Plan
   HYPOXEMIA -- attributed to new pneumonia on background of RSV
   infection.   No evidence for pulmonary embolism by today's CT scan.
   Evidence for new pulmonary infiltrates on right and left upper lobes
   --> possibly representing new infection or process (ex. PcP or other
   fungal infection), progression of underlying infection, complication of
   medications (ex. related to rash, related to antibody administration).
   Plan continue supplimental oxygen, monitor RR, maintain SaO2 > 90%,
   continue empirical antimicrobials.  Provide beta-agonist.  Check on
   next scheduled PcP prophylaxis Would check LE NIVS to assess for DVT.
   Check beta-galactomannan.  Consider bronchoscopy, although would
   require intubation to perform procedure safely.  Low threshold for
   intubation in event of clinical decline.
   PNEUMONIA (HAP) -- clinical variability on current regimen.  Doubt OI.
   Consider bronchoscopic investigation.  Continue current level of care.
   Interval development of multiple pulmonary infiltates  may represent
   aspiration or atuypical pneuonia, but may also represent process such
   as right-sided endovascular infeciton (ex. endocarditis, line-related
   infection).  Check blood cultures, consider repeat echo.
   RSV infection -- s/p antibody treatment.
   Cough -- attributed to RSV and HAP.  Improving.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye (CT angio).
   CML s/p SCT c/b GVHD
 continue current level of care.
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with suppliments.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   20 Gauge - [**2104-12-14**] 10:59 AM
   Prophylaxis:
   DVT: Boots(Systemic anticoagulation: None)
   Stress ulcer: H2 blocker
   VAP: HOB elevation
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 78-year-old male admitted to the ICU with respiratory distress, hypoxemia, and a history of RSV infection, pneumonia, and CML s/p SCT with cGVHD. The patient has been receiving empirical antimicrobials and supplemental oxygen.

Potential medical complications that can arise include:

1. Pneumonia progression: The patient has new pulmonary infiltrates on CT scan, which may represent progression of underlying infection, complication of medications, or new infection. This could lead to worsening respiratory distress, sepsis, and potential organ failure.
2. Respiratory failure: The patient's hypoxemia and respiratory distress may progress to respiratory failure, requiring intubation and mechanical ventilation.
3. Sepsis: The patient's pneumonia and RSV infection may lead to sepsis, which could result in organ failure, disseminated intravascular coagulation, and death.
4. Cytomegalovirus (CMV) reactivation: The patient's history of CML and cGVHD may increase the risk of CMV reactivation, which could lead to CMV disease and potentially life-threatening complications.
5. Gastrointestinal (GI) GVHD: The patient's GI GVHD may worsen, leading to GI bleeding, perforation, and potential life-threatening complications.
6. Nutritional deficiencies: The patient's inability to take oral nutrition and potential GI GVHD may lead to nutritional deficiencies, which could exacerbate his underlying conditions.
7. Depression: The patient's depressed mood may worsen, leading to decreased appetite, social withdrawal, and potential suicidal thoughts.
8. Central line-associated bloodstream infections (CLABSIs): The patient's central lines may become infected, leading to sepsis, bacteremia, and potential organ failure.
9. Venous thromboembolism (VTE): The patient's history of CML and cGVHD may increase the risk of VTE, which could lead to pulmonary embolism, deep vein thrombosis, and potential life-threatening complications.
10. Skin rash: The patient's new skin rash may worsen, leading to increased risk of infection, skin breakdown, and potential life-threatening complications.

To address these potential complications, the patient requires close monitoring, aggressive treatment of underlying infections, and prompt management of any new complications that arise."
101091.0,273922,2104-12-15 05:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Bronchial:
   , Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Appears to have been acute in onset, patient without any
   major complaints at the time.  ABG showing PaO2 of 65.  Differential
   includes PE, COPD exacerbation, worsening pneumonia or fungal
   infection, worsening bronchiolitis.  Also possible endovascular issue
   given indwelling line (Hickman) and multifocal pneumonia).Patient did
   have a CTA on [**12-5**] showing stable emphysema and no evidence of PE.
   Additionally, patient rapidly improved his oxygenation from requiring a
   NRB to maintaining sats in the mid-90s on 6L NC after receiving
   nebulizer treatments.  CXR wtihout any acute change from prior.
   Patient feels well except for ongoing cough
   - CTA now - prelim read: no e/o PE, but LLL infiltrate as well as new
   foci of infiltrate in LUL and RUL concerning for fungal or other
   organism.
   - Follow up final read CT
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - Continue broad spectrum abx with vanc/cefepime.  Also receiving
   posaconazole ppx, gets pentamidine as outpatient, will check date.
   Patient with no atypical coverage at this time, will discuss with ID as
   below.
   - Contact ID re: abx recommendations as patient is on broad spectrum
   and fungal coverage
   - Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced.  Unclear when rash began, though it
   appears to be new today.  Patient does not recall having had it prior,
   and nursing from BMT floor did not report it to nursing.  Cause
   includes drug-induced from cefepime (patient is allergic to pen VK -
   will clarify if reaction was a rash) though he has been on this
   multiple times in the past.  Also could be secondary to IV contrast
   though from CTA today as nursing does not think rash was present prior,
   though he has had IV contrast in the past as well.  No other apparent
   new drugs
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   - Check ECG now
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: (Expansion: Symmetric), (Breath Sounds: Bronchial:
   , Rhonchorous: )
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Appears to have been acute in onset, patient without any
   major complaints at the time.  ABG showing PaO2 of 65.  Differential
   includes PE, COPD exacerbation, worsening pneumonia or fungal
   infection, worsening bronchiolitis.  Also possible endovascular issue
   given indwelling line (Hickman) and multifocal pneumonia).Patient did
   have a CTA on [**12-5**] showing stable emphysema and no evidence of PE.
   Additionally, patient rapidly improved his oxygenation from requiring a
   NRB to maintaining sats in the mid-90s on 6L NC after receiving
   nebulizer treatments.  CXR wtihout any acute change from prior.
   Patient feels well except for ongoing cough
   - CTA now - prelim read: no e/o PE, but LLL infiltrate as well as new
   foci of infiltrate in LUL and RUL concerning for fungal or other
   organism.
   - Follow up final read CT
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - Continue broad spectrum abx with vanc/cefepime.  Also receiving
   posaconazole ppx, gets pentamidine as outpatient, will check date.
   Patient with no atypical coverage at this time, will discuss with ID as
   below.
   - Contact ID re: abx recommendations as patient is on broad spectrum
   and fungal coverage
   - Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced.  Unclear when rash began, though it
   appears to be new today.  Patient does not recall having had it prior,
   and nursing from BMT floor did not report it to nursing.  Cause
   includes drug-induced from cefepime (patient is allergic to pen VK -
   will clarify if reaction was a rash) though he has been on this
   multiple times in the past.  Also could be secondary to IV contrast
   though from CTA today as nursing does not think rash was present prior,
   though he has had IV contrast in the past as well.  No other apparent
   new drugs
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   - Check ECG now
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He is currently admitted to the Intensive Care Unit (ICU) with acute hypoxia, hospital-acquired pneumonia, and bronchiolitis.

The patient's vital signs are stable, with a temperature of 36.7°C, heart rate of 88 bpm, blood pressure of 92/58 mmHg, and oxygen saturation of 93%. His respiratory support includes nasal cannula oxygen delivery and nebulizer treatments.

The patient's laboratory results show mild leukopenia, anemia, and thrombocytopenia, which are consistent with his history of CML and GVHD. His blood cultures are positive, and he has been treated with broad-spectrum antibiotics, including vancomycin and cefepime.

The patient's radiology results show stable emphysema on computed tomography (CT) scan, with no evidence of pulmonary embolism (PE). However, his CT scan also shows new foci of infiltrate in the left lower lobe (LLL) and right upper lobe (RUL), which are concerning for fungal or other organisms.

The patient's plan includes continuation of broad-spectrum antibiotics, posaconazole prophylaxis, and nebulizer treatments. He will also undergo bronchoscopy for further characterization of the infectious process, and blood cultures will be obtained if cultures are positive. Additionally, he will receive inhaled pentamidine as an outpatient and continue to receive immunosuppressive therapy for GVHD.

Potential medical complications that can arise include:

1. Respiratory failure: The patient's acute hypoxia and bronchiolitis may lead to respiratory failure, which could require intubation and mechanical ventilation.
2. Sepsis: The patient's positive blood cultures and multifocal pneumonia may lead to sepsis, which could cause organ dysfunction and increased mortality.
3. Fungal infection: The patient's posaconazole prophylaxis and new foci of infiltrate on CT scan suggest the possibility of fungal infection, which could be life-threatening.
4. Gastrointestinal bleeding: The patient's GVHD and immunosuppressive therapy may increase the risk of gastrointestinal bleeding, which could be life-threatening.
5. Cardiac complications: The patient's history of CML and GVHD may increase the risk of cardiac complications, such as arrhythmias, congestive heart failure, and cardiac arrest.
6. Neurological complications: The patient's immunosuppressive therapy and GVHD may increase the risk of neurological complications, such as seizures, encephalopathy, and meningitis.

It is essential to closely monitor the patient's condition and adjust his treatment plan as needed to prevent and manage these potential complications."
101091.0,273922,2104-12-15 05:44:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Antibiotic regimen changed to Linezolid/Aztreonam per ID
   recommendations; also on Cipro.
   No other overnight events; pt continue to be on 6L NC.  Not complaining
   of worsening cough or SOB.  Rash appears worse but non-pruritic.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 6L
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   Antibiotic regimen changed to Linezolid/Aztreonam per ID
   recommendations; also on Cipro.
   No other overnight events; pt continue to be on 6L NC.  Not complaining
   of worsening cough or SOB.  Rash appears worse but non-pruritic.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-15**] 12:20 AM
   Linezolid - [**2104-12-15**] 04:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 05:43 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.7
C (98
   HR: 88 (84 - 108) bpm
   BP: 92/58(66) {90/52(62) - 129/79(90)} mmHg
   RR: 21 (14 - 26) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    407 mL
   PO:
                                                                    340 mL
                                                                    250 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    157 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                   -143 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula 6L
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   329 K/uL
   11.1 g/dL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the Intensive Care Unit (ICU) with acute hypoxia and hospital-acquired pneumonia. He is currently receiving broad-spectrum antibiotics, antifungals, and antiviral prophylaxis.

The patient's vital signs are stable, with a temperature of 37.9°C, heart rate of 88 bpm, and blood pressure of 92/58 mmHg. He is receiving oxygen therapy at 6 liters per minute and is being monitored for hypoxia.

The patient's laboratory results show an elevated white blood cell count (WBC) of 13.6 K/uL and a decreased platelet count (Plt) of 142 K/uL. His blood cultures have shown spikes, and he is being treated for possible pneumonia.

The patient's rash appears to be drug-induced, possibly caused by cefepime or IV contrast. He is being monitored for possible GVHD and is receiving symptomatic treatment for the rash.

Potential Medical Complications:

1. Pneumonia: The patient's hospital-acquired pneumonia is being treated with broad-spectrum antibiotics, but there is a risk of complications such as respiratory failure or sepsis.
2. GVHD: The patient's history of GVHD and current symptoms suggest that he may be experiencing a flare-up of the condition. This could lead to complications such as skin rash, diarrhea, or liver dysfunction.
3. Cardiomyopathy: The patient's history of cardiomyopathy and current symptoms suggest that he may be experiencing a flare-up of the condition. This could lead to complications such as heart failure or arrhythmias.
4. Hypoxia: The patient's hypoxia is being treated with oxygen therapy, but there is a risk of complications such as respiratory failure or sepsis.
5. Infection: The patient's elevated WBC count and positive blood cultures suggest that he may be at risk for infection. This could lead to complications such as sepsis or organ failure.

Recommendations:

1. Continue to monitor the patient's vital signs and laboratory results to ensure that he is responding to treatment.
2. Consider bronchoscopy to further characterize the patient's infectious process.
3. Continue to treat the patient's pneumonia with broad-spectrum antibiotics.
4. Monitor the patient for signs of GVHD and adjust his immunosuppressive therapy as necessary.
5. Consider increasing the patient's oxygen therapy if his hypoxia persists.
6. Monitor the patient for signs of infection and adjust his antibiotic therapy as necessary."
101091.0,273922,2104-12-15 10:20:00,Physician ,Physician Attending Progress Note,"Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (SCT) and developed graft-versus-host disease (GVHD). The patient was admitted to the ICU with hypoxemic respiratory distress due to respiratory syncytial virus (RSV) bronchiolitis and respiratory distress.

The patient's current condition is as follows:

* Respiratory: The patient is receiving supplemental oxygen and has a SpO2 of 87%. The patient has a history of RSV infection and is being treated with antibiotics. The patient's chest X-ray shows multifocal infiltrates, and the patient is being monitored for possible pulmonary embolism (PE).
* Cardiovascular: The patient's blood pressure is 83/55 mmHg, and the patient's heart rate is 90 beats per minute. The patient's peripheral pulses are not assessed due to the patient's condition.
* Neurological: The patient's mental status is not assessed due to the patient's respiratory distress.
* Laboratory results: The patient's white blood cell count is 10.3, and the patient's platelet count is 142. The patient's creatinine level is 1.3, and the patient's glucose level is 90.

The patient's potential medical complications include:

* Recurrent bacterial pneumonia
* Pneumocystis pneumonia (PCP)
* Fungal process
* GVHD
* Intubation
* Respiratory failure
* Sepsis

The patient's plan of care includes:

* Continue supplemental oxygen
* Monitor respiratory rate and maintain SaO2 > 90%
* Continue empirical antimicrobials
* Provide beta-agonist
* Check on next scheduled PCP
* Consider bronchoscopy
* Low threshold for intubation in event of clinical decline
* Continue current level of care
* Will discuss with BMT service re: IvIg therapy and possible modification of steroid regimen
* Continue oral swish and spit for GI GVHD
* Encourage PO with supplements
* Keep npo for possible bronchoscopy
* Consider pharmacological intervention for depressed mood

The patient's ICU care includes:

* Nutrition: Glycemic control, blood sugar well controlled
* Lines: Tunneled Hickman line
* Prophylaxis: DVT, stress ulcer
* VAP: Not assessed

The patient's code status is full code, and the patient's disposition is ICU. The patient's total time spent in the ICU is 50 minutes."
101091.0,273922,2104-12-15 10:20:00,Physician ,Physician Attending Progress Note,"Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: hypoxemic respiratory distress
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   55 yo CML s/p MUD SCT c/b GVHD. Admitted w/ RSV bronchiolitis and resp
   distress initially to [**Hospital Unit Name 10**] in late [**11-17**], transferred to floor, then
   re-admitted to [**Hospital Unit Name 10**] [**2104-12-14**] with progressive hypoxemia (4L NC to NRB) in
   the setting of relatively new pulm infiltrate. CT chest [**12-14**] showed
   progression of multifocal infiltrates. Per ID rec's had viral work-up
   sent, IVIg started.
   24 Hour Events:
 TUNNELED (HICKMAN) LINE - START [**2104-12-14**] 10:58 AM
 BLOOD CULTURED - At [**2104-12-14**] 04:45 PM
   1x1 . Sample drawn from Hickmann
   No other events.
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-15**] 04:00 AM
   Aztreonam - [**2104-12-15**] 08:00 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-14**] 08:40 PM
   Heparin Sodium (Prophylaxis) - [**2104-12-15**] 08:00 AM
   Other medications:
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-15**] 10:20 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37.9
C (100.2
   Tcurrent: 36.4
C (97.6
   HR: 90 (81 - 108) bpm
   BP: 83/55(60) {83/52(60) - 129/79(90)} mmHg
   RR: 18 (14 - 26) insp/min
   SpO2: 87%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    570 mL
                                                                    696 mL
   PO:
                                                                    340 mL
                                                                    400 mL
   TF:
   IVF:
                                                                    230 mL
                                                                    296 mL
   Blood products:
   Total out:
                                                                    400 mL
                                                                    550 mL
   Urine:
                                                                    400 mL
                                                                    550 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    170 mL
                                                                    146 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 87%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : L base)
   Abdominal: Soft, Non-tender
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, Rash: maculopap on trunk and neck
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   11.1 g/dL
   329 K/uL
   101 mg/dL
   1.0 mg/dL
   30 mEq/L
   4.0 mEq/L
   10 mg/dL
   105 mEq/L
   142 mEq/L
   33.9 %
   13.6 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   Plt
   [**Telephone/Fax (2) 3249**]
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   Other labs: Differential-Neuts:81.0 %, Band:0.0 %, Lymph:5.0 %,
   Mono:9.0 %, Eos:4.0 %, Ca++:8.9 mg/dL, Mg++:1.9 mg/dL, PO4:3.6 mg/dL
   Fluid analysis / Other labs: galactomannan- neg
   bD-glucan- neg
   Imaging: CT Chest ([**2104-12-14**])- L apical blebs, patchy ground glass
   throughout all lobes, dense infiltrates B bases
   Microbiology: Blood- pending
   Sputum- nl flora
   Rapid viral Ag- neg
   CMV VL- pending
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT. DDx includes recurr bact pneumonia,
   PCP or fungal process. Also consider GVHD. Plan continue supplemental
   oxygen, monitor RR, maintain SaO2 > 90%, continue empirical
   antimicrobials.  Provide beta-agonist.  Check on next scheduled PcP
   [**Name Initial (PRE) 3261**]. Consider bronchoscopy this afternoon. Low threshold for
   intubation in event of clinical decline.
   RSV infection -- s/p antibody treatment.
   RASH -- new development;  appears drug-related, and currently receiving
   several potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :ICU
   Total time spent: 50 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of their condition and potential medical complications:

Patient Summary:

* The patient is a 55-year-old male with chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (SCT) and developed graft-versus-host disease (GVHD).
* He was admitted to the ICU with respiratory distress and hypoxemia due to RSV bronchiolitis and a new pulmonary infiltrate.
* He has been receiving oxygen therapy, empirical antimicrobials, and beta-agonist medication.
* His current vital signs include a temperature of 36.4°C, heart rate of 90 bpm, blood pressure of 83/55 mmHg, respiratory rate of 18 breaths per minute, and oxygen saturation of 87%.
* His laboratory results show a white blood cell count of 10.3 K/μL, hemoglobin of 11.1 g/dL, and platelet count of 329 K/μL.
* He has a rash on his trunk and neck, which is suspected to be drug-related.
* He is receiving nutrition support and has a code status of full code.

Potential Medical Complications:

* Respiratory failure: The patient's hypoxemia and respiratory distress may worsen, leading to respiratory failure, which could require mechanical ventilation.
* Pneumonia: The patient's new pulmonary infiltrate may be due to pneumonia, which could progress to bacteremia or other complications.
* GVHD: The patient's GVHD may worsen, leading to multi-organ failure or other complications.
* Infection: The patient's immunosuppressed state makes him prone to infections, including sepsis or other complications.
* Bleeding: The patient's platelet count is low, which may increase the risk of bleeding complications.
* Nutritional deficiencies: The patient's malnutrition may worsen, leading to complications such as decreased immune function or wound healing issues.
* Depressed mood: The patient's depressed mood may worsen, leading to decreased quality of life or increased risk of suicide."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   Bronchoscopy not performed yesterday is scheduled for today. Pt was
   also started on flagyl for aneorobic coverage per ID recs. Yesterday am
   his rash was found to have spread to his legs and become more confluent
   on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   Bronchoscopy not performed yesterday is scheduled for today. Pt was
   also started on flagyl for aneorobic coverage per ID recs. Yesterday am
   his rash was found to have spread to his legs and become more confluent
   on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Crackles at both bases, R>L
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso and neck, extending
   to lower legs and arms; all areas except face.  Rash is blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Chest CT with new foci of
   infiltrate in LUL and RUL although has been on broad-spectrum abx and
   antifungals.  PCP less likely given presentation although possible
   given prednisone use.
   - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 = [**2103-12-14**]);
   had received 7 days of Vanc/Cefepime prior to this.  Cipro started
   [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] Consider bronchoscopy for further characterization of infectious
   process, patient will likely need to be intubated for procedure.
   - Blood cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: continue immunosuppression as per BMT
   team with prednisone, neoral and cellcept.  Picture not consistent with
   PCP. [**Name Initial (NameIs) 3160**]/galactomannan negative, and given posaconazole
   prophylaxis, unlikely aspergillus pneumonia.  ? if this rash is
   manifestation of GVHD as well vs. drug rash.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   - discuss with BMT team utility of high dose steroids for possible GVHD
   of lung or skin
   - possible IVIG today per BMT
   .
   # Rash: Appears to be drug induced.  Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, here is a summary of the information and potential medical complications that can arise:

**Current Status:**

* The patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and is now experiencing graft-versus-host disease (GVHD) of the skin and gut.
* He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia, and is currently on 6L nasal cannula oxygen.
* The patient's rash has spread to his legs and arms, and is blanching.

**Assessment and Plan:**

* The patient's hypoxia has improved since admission to the ICU, but he still requires oxygen therapy.
* The patient is being treated with broad-spectrum antibiotics and antifungals, but the etiology of his pneumonia is still unclear.
* The patient is also being treated for GVHD with immunosuppressive medications, including prednisone, neoral, and cellcept.
* The rash is likely drug-induced, possibly due to cefepime or IV contrast, but could also be a manifestation of GVHD.
* The patient's cardiomyopathy is being managed with outpatient metoprolol XL, and his electrolyte levels are being monitored.
* The patient's nutrition is being managed with a cardiac diet, and his glycemic control is being monitored.

**Potential Medical Complications:**

* Pneumonia: The patient's pneumonia is still unclear, and the risk of further complications, such as sepsis or respiratory failure, is high.
* GVHD: The patient's GVHD is being managed with immunosuppressive medications, but the risk of further complications, such as skin or gut failure, is high.
* Cardiomyopathy: The patient's cardiomyopathy is being managed with outpatient metoprolol XL, but the risk of further complications, such as heart failure or arrhythmias, is high.
* Hypoxia: The patient's hypoxia is being managed with oxygen therapy, but the risk of further complications, such as respiratory failure, is high.
* Rash: The patient's rash is likely drug-induced, but the risk of further complications, such as skin failure or infection, is high.

**Recommendations:**

* Continue to monitor the patient's respiratory status and adjust oxygen therapy as needed.
* Continue to manage the patient's GVHD with immunosuppressive medications and monitor for signs of skin or gut failure.
* Continue to manage the patient's cardiomyopathy with outpatient metoprolol XL and monitor for signs of heart failure or arrhythmias.
* Continue to monitor the patient's electrolyte levels and adjust therapy as needed.
* Consider bronchoscopy to further characterize the patient's infectious process and adjust therapy accordingly.
* Consider IVIG to treat the patient's hypogammaglobulinemia and reduce the risk of further complications."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia, and is currently in the intensive care unit (ICU) with acute hypoxia.

The patient's current condition is as follows:

* Respiratory status: The patient is receiving 6L of nasal cannula oxygen and has improved since admission to the ICU. A portable chest X-ray performed yesterday showed pneumonia to be resolving.
* Hemodynamic status: The patient's blood pressure is stable, and his heart rate is within normal limits.
* Laboratory results: The patient's white blood cell count is increasing, and his platelet count is stable. His creatinine level is within normal limits, and his glucose level is controlled.
* Skin rash: The patient has a diffuse maculopapular rash on his torso, back, and neck, which is thought to be drug-induced, possibly related to cefepime or IV contrast.

Potential medical complications that can arise from the patient's current condition include:

* Pneumonia progression: Despite the patient's pneumonia being resolved on chest X-ray, there is still a risk of progression or recurrence.
* Respiratory failure: The patient's acute hypoxia requires close monitoring, and there is a risk of respiratory failure if oxygen therapy is not effective.
* GVHD: The patient's history of GVHD and current immunosuppressive therapy put him at risk for further GVHD complications, such as gut GVHD or skin GVHD.
* Infection: The patient's immunosuppressive state and history of hospital-acquired pneumonia put him at risk for further infections, such as bacterial or fungal infections.
* Cardiomyopathy: The patient's history of cardiomyopathy and current hypoxia may exacerbate his condition, leading to decompensated heart failure.

Based on the patient's current condition and potential complications, the following plan is recommended:

* Continue antibiotic therapy for pneumonia and bronchiolitis.
* Monitor the patient's respiratory status closely and adjust oxygen therapy as needed.
* Continue immunosuppressive therapy for GVHD.
* Monitor the patient's skin rash and adjust treatment as necessary.
* Continue to monitor the patient's laboratory results, including white blood cell count, platelet count, and creatinine level.
* Consider bronchoscopy to assess PNA progress and rule out other respiratory infections.
* Continue to wean oxygen as needed and monitor the patient's cardiomyopathy status."
101091.0,273922,2104-12-16 06:34:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   -Pt was given IVIG per heme/onc for his hypogammaglobulinemia.
   -Pt was also started on flagyl for aneorobic coverage per ID recs.
   -Yesterday am his rash was found to have spread to his legs and become
   more confluent on his chest.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Aztreonam - [**2104-12-16**] 12:03 AM
   Acyclovir - [**2104-12-16**] 12:04 AM
   Metronidazole - [**2104-12-16**] 12:04 AM
   Linezolid - [**2104-12-16**] 04:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 12:03 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 06:30 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 37
C (98.6
   HR: 88 (81 - 103) bpm
   BP: 99/53(65) {77/42(52) - 114/75(83)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 94%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    165 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    165 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                   -235 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 94%
   ABG: ///30/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   293 K/uL
   10.6 g/dL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: cardiac diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:  Heparin SC
   Stress ulcer:  Omeprazole 20mg PO BID
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: ICU level of care pending possible bronch today and O2
   requirements<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of Chronic Myeloid Leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia. The patient's condition has improved since admission, with resolution of pneumonia on portable chest x-ray and improvement in oxygenation. He is currently on oxygen therapy and antibiotics.

The patient has a rash that has spread to his legs and chest, which is suspected to be drug-induced, possibly related to cefepime or IV contrast. He has a history of allergy to penicillin VK and has received cefepime in the past without reaction. The rash is being monitored, and symptomatic treatment is being considered if necessary.

The patient's cardiomyopathy is being managed with outpatient metoprolol XL, and his hypoxia is unlikely related to acute coronary syndrome (ACS) given its improvement with nebulizers.

The patient has a history of GVHD and is receiving immunosuppressive therapy. He is also receiving antifungal and antiviral prophylaxis.

Potential Medical Complications:

1. Worsening of GVHD: The patient's GVHD is being managed with immunosuppressive therapy, but it is possible that the condition could worsen, leading to further complications.
2. Infection: The patient is at risk for infection due to his immunocompromised state and presence of central venous catheters.
3. Cardiac complications: The patient's cardiomyopathy could worsen, leading to cardiac complications such as heart failure or arrhythmias.
4. Respiratory complications: The patient's hypoxia could worsen, leading to respiratory failure or acute respiratory distress syndrome (ARDS).
5. Gastrointestinal complications: The patient's GVHD could lead to gastrointestinal complications such as diarrhea, abdominal pain, or bleeding.
6. Neurological complications: The patient's GVHD could lead to neurological complications such as seizures, encephalitis, or Guillain-Barré syndrome.

Recommendations:

1. Continue to monitor the patient's condition closely for signs of worsening GVHD, infection, or cardiac complications.
2. Consider adjusting immunosuppressive therapy if GVHD worsens.
3. Continue antifungal and antiviral prophylaxis to prevent opportunistic infections.
4. Monitor the patient's cardiomyopathy and adjust therapy as necessary.
5. Continue to wean oxygen therapy as the patient's oxygenation improves.
6. Consider bronchoscopy if the patient's respiratory status worsens or if there is concern for pneumonia."
101091.0,273922,2104-12-16 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG last PM, started on Flagyl. Rash is spreading despite stopping
   Cefopime, continuing on 6 liters. WBC down significantly. Afebrile last
   24 hrs
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG last PM, started on Flagyl. Rash is spreading despite stopping
   Cefopime, continuing on 6 liters. WBC down significantly. Afebrile last
   24 hrs
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following summary and potential medical complications can be determined:

**Summary:**

The patient is a critically ill individual with PNA, RSV bronchiolitis, and hypoxia. The patient has received various treatments, including IV IG, antibiotics, and other medications. The patient's condition has shown some improvement, with decreased WBC count and afebrile status for the past 24 hours. However, the patient still requires respiratory support and has a diffuse maculopapular rash that is attributed to potential drug-related causes.

**Potential Medical Complications:**

1. **Pneumonia:** The patient has developed a new pneumonia, which may worsen their condition and increase the risk of respiratory failure.
2. **RSV infection:** The patient has ongoing RSV infection, which can lead to further complications, such as bronchiolitis and respiratory distress.
3. **Rash:** The patient's rash is attributed to potential drug-related causes, which may indicate an allergic reaction or toxicity. Monitoring and adjusting medications may be necessary to prevent further complications.
4. **Gastrointestinal GVHD:** The patient has ongoing GI GVHD, which can lead to gastrointestinal bleeding, diarrhea, and malnutrition.
5. **Depressed mood:** The patient's depressed mood may indicate a need for pharmacological intervention or psychological support to manage their mental health.
6. **Nutritional support:** The patient may require ongoing nutritional support to maintain their caloric intake and prevent malnutrition.
7. **Infections:** The patient is at risk of developing infections, particularly pneumonia and sepsis, due to their compromised immune system.
8. **Hepatic dysfunction:** The patient's liver function tests are abnormal, which may indicate liver dysfunction or damage.
9. **Renal dysfunction:** The patient's creatinine levels are elevated, which may indicate kidney dysfunction or damage.
10. **Cardiovascular complications:** The patient's cardiac status is compromised, and they may be at risk of developing cardiovascular complications, such as arrhythmias or heart failure."
101091.0,273922,2104-12-16 10:36:00,Physician ,Physician Attending Progress Note,"Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG, bronch pending, starting on Flagyl. Rash is spreading despite
   stopping Cefopime, continuing on 6 liters
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvment favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint: PNA, RSV Bronchiolitis, Hypoxia
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   IV IG, bronch pending, starting on Flagyl. Rash is spreading despite
   stopping Cefopime, continuing on 6 liters
   History obtained from Patient
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-16**] 08:00 AM
   Acyclovir - [**2104-12-16**] 08:00 AM
   Metronidazole - [**2104-12-16**] 08:00 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-16**] 08:00 AM
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Other medications:
   nebs q6, prednisone, hep SQ, dexamethasone swish and spit, MVI, Mag OX,
   Vit D, CaCO3, Vit C, Ursadiol, Ompeprazole, Cellcept, Folic A,
   Posiconizole, Cyclosporin, Acyclovir
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-16**] 10:36 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 37
C (98.6
   Tcurrent: 36.6
C (97.8
   HR: 96 (84 - 103) bpm
   BP: 99/54(64) {77/42(52) - 118/78(86)} mmHg
   RR: 17 (15 - 23) insp/min
   SpO2: 93%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                  1,479 mL
                                                                    303 mL
   PO:
                                                                    795 mL
             TF:
   IVF:
                                                                    484 mL
                                                                    303 mL
   Blood products:
                                                                    200 mL
   Total out:
                                                                    900 mL
                                                                    400 mL
   Urine:
                                                                    900 mL
                                                                    400 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    579 mL
                                                                    -97 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 93%
   ABG: ///30/
   Physical Examination
   General Appearance: No acute distress
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g, distant HS
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: No(t) Clear : , Diminished:
   throughout)
   Extremities: Right: Absent, Left: Absent
   Skin:  Not assessed, diffuse maculopap rash more confluent today
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.6 g/dL
   293 K/uL
   110 mg/dL
   1.0 mg/dL
   30 mEq/L
   3.3 mEq/L
   14 mg/dL
   106 mEq/L
   142 mEq/L
   32.0 %
   9.0 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   Other labs: PT / PTT / INR:12.7/45.1/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.4 mg/dL,
   Mg++:2.0 mg/dL, PO4:3.1 mg/dL
   Assessment and Plan
   HYPOXEMIA -- Attributed to new pneumonia on background of RSV
   infection. r/o for PE on [**12-14**] CT.
   -given clinical improvment favor bacterial nosocomial pna most likely;
   complete 8d course
   -encourage ambulation
   -defer bronch for now
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimem
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements. Keep npo for poss
   bronch this pm
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :
   Total time spent: 45 minutes
   Patient is critically ill<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the patient's progress note, the following information can be summarized:

The patient is a 78-inch tall, 76 kg male with a chief complaint of PNA (pneumonia) and RSV bronchiolitis, accompanied by hypoxia. The patient has a history of CML (chronic myeloid leukemia) and has undergone SCT (stem cell transplant) with a diagnosis of GVHD (graft-versus-host disease).

The patient's vital signs are:

* Temperature: 36.6°C (97.8°F)
* Heart rate: 96 bpm (84-103 bpm)
* Blood pressure: 99/54 mmHg (64-118/78 mmHg)
* Respiratory rate: 17 breaths per minute (15-23 breaths per minute)
* Oxygen saturation: 93%
* Hemodynamic monitoring: stable

The patient's physical examination reveals:

* General appearance: no acute distress
* Cardiovascular: normal S1 and S2 sounds, no murmurs or gallop
* Respiratory/chest: breath sounds are diminished throughout
* Extremities: right and left radial pulses are absent
* Skin: diffuse maculopapular rash more confluent today
* Neurologic: responds to stimuli, movement, and tone are not assessed

Laboratory results include:

* White blood cell count: 10.3-13.6 x 10^9/L
* Hemoglobin: 10.6-12.4 g/dL
* Platelet count: 293-9.0 x 10^9/L
* Creatinine: 0.9-1.3 mg/dL
* Glucose: 90-110 mg/dL
* Other labs: PT/PTT/INR, differential count, calcium, magnesium, and phosphorus levels are within normal ranges.

The patient's plan includes:

* Completion of an 8-day course of antibiotics for pneumonia
* Encouragement of ambulation
* Deferral of bronchoscopy for now
* Continued treatment for RSV infection with antibody therapy
* Monitoring for signs of GVHD
* Modification of steroid regimen as needed
* Nutritional support with oral supplements and potential nasogastric feeding
* Depression management with pharmacological intervention as needed
* Continued ICU care with close monitoring of vital signs and laboratory results.

Potential medical complications that may arise include:

* Bacterial nosocomial pneumonia
* Respiratory failure
* Sepsis
* GVHD
* Nutritional deficiencies
* Depression
* Hypoglycemia
* Hypocalcemia
* Hypomagnesemia
* Hypophosphatemia
* Thrombocytopenia
* Anemia
* Hyperbilirubinemia

It is essential to closely monitor the patient's condition and adjust the plan as needed to prevent and manage these potential complications."
101091.0,273922,2104-12-17 07:35:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 3L
   - no bronch done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Middle-aged male lying in bed in NAD
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: RRR, no MRG
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: no edema
   Skin:  Warm, Rash improving: diffuse maculopapular over torso, back and
   neck, extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, alert and oriented x3
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, transferred to the ICU with acute hypoxia now
   improved.
   # Hypoxia: Improved since admission to the ICU, now on 3L NC. Pt has
   been afebrile and his leukocytosis appears to be improving on his
   current antibiotic regimen. Will defer from bronchoscopy given his
   improvement in clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]), Aztreonam (day #1 = [**2103-12-14**]),
   cipro (day #1 [**12-14**]), and flagyl (day #1 [**12-16**]) ; had received 7 days of
   Vanc/Cefepime prior to this.   Will need an 8 day course from [**12-14**].
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   # Tachycardia: Patient has been in sinus tach on tele in the 90
s to
   100
s.  Is on 150 mg Toprol daily as an outpatient which has been held
   here.  Does not appear to be in pain, oxygenation is improving (no
   evidence of PE), and he appears to be euvolemic.
   - Start metoprolol 50 mg po bid.
   - Continue to monitor.
   # CML s/p transplant and GVHD: Pt received IVIG recently per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   # Rash: His rash is improving.  Was thought to be drug induced, may be
   related to Cefepime as he does have an allergy history to PCN V however
   he has received Cefepime in the past without any reactions.  Possible
   GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   # Cardiomyopathy. Unlikely that his hypoxia is related to ACS as it
   improved with nebulizers.  No PND/orthopnea or other signs of
   decompensated heart failure.
   - Restart metoprolol as above.
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:  N/A
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Call out to the floor
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 3L
   - no bronch done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Middle-aged male lying in bed in NAD
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: RRR, no MRG
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: no edema
   Skin:  Warm, Rash improving: diffuse maculopapular over torso, back and
   neck, extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, alert and oriented x3
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, transferred to the ICU with acute hypoxia now
   improved.
   # Hypoxia: Improved since admission to the ICU, now on 3L NC. Pt has
   been afebrile and his leukocytosis appears to be improving on his
   current antibiotic regimen. Will defer from bronchoscopy given his
   improvement in clinical status on his current antibiotics.
    - continue Linezolid (day #1 = [**2103-12-14**]), Aztreonam (day #1 = [**2103-12-14**]),
   cipro (day #1 [**12-14**]), and flagyl (day #1 [**12-16**]) ; had received 7 days of
   Vanc/Cefepime prior to this.   Will need an 8 day course from [**12-14**].
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   # Tachycardia: Patient has been in sinus tach on tele in the 90
s to
   100
s.  Is on 150 mg Toprol daily as an outpatient which has been held
   here.  Does not appear to be in pain, oxygenation is improving (no
   evidence of PE), and he appears to be euvolemic.
   - Start metoprolol 50 mg po bid.
   - Continue to monitor.
   # CML s/p transplant and GVHD: Pt received IVIG recently per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   # Rash: His rash is improving.  Was thought to be drug induced, may be
   related to Cefepime as he does have an allergy history to PCN V however
   he has received Cefepime in the past without any reactions.  Possible
   GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   # Cardiomyopathy. Unlikely that his hypoxia is related to ACS as it
   improved with nebulizers.  No PND/orthopnea or other signs of
   decompensated heart failure.
   - Restart metoprolol as above.
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition: regular diet
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQH
   Stress ulcer: PPI
   VAP:  N/A
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition: Call out to the floor<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the hospital with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia (HAP). He was transferred to the intensive care unit (ICU) due to acute hypoxia and has since improved with oxygen therapy.

The patient's current condition is as follows:

* Respiratory: Improved with oxygen therapy, but still has diminished breath sounds and crackles at the right base.
* Cardiovascular: In sinus tachycardia, but not in pain, and appears to be euvolemic.
* Hematological: Leukocytosis appears to be improving on current antibiotic regimen.
* Skin: Rash is improving, but may be related to GVHD or drug-induced.

Potential Medical Complications:

* Respiratory: Pneumonia may progress, leading to respiratory failure.
* Cardiovascular: Tachycardia may lead to cardiac arrhythmias or heart failure.
* Hematological: Leukocytosis may persist, leading to bleeding or infection.
* Skin: GVHD may worsen, leading to skin lesions or infections.
* Infections: HAP may progress, leading to sepsis or other complications.

Plan:

* Continue current antibiotic regimen and monitor for improvement.
* Wean oxygen therapy as needed.
* Start metoprolol 50 mg po bid to control tachycardia.
* Continue to monitor for GVHD and skin lesions.
* Consider ECHO if cultures are positive.
* Continue prophylactic agents for GVHD, antifungals, and acyclovir.
* Restart metoprolol as above for cardiomyopathy.
* Continue to monitor for cardiomyopathy and cardiac arrhythmias.
* Continue to monitor for infections and sepsis.
* Consider restarting pentamadine for PCP prophylaxis."
101091.0,273922,2104-12-17 07:35:00,Physician ,Physician Resident Progress Note,"TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 4L
   - no broncho done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

TITLE:
   Chief Complaint:
   24 Hour Events:
   - O2 weaned down to 4L
   - no broncho done as clinically improving, likely has HAP and is
   responding to treatment
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 12:08 AM
   Acyclovir - [**2104-12-17**] 12:08 AM
   Metronidazole - [**2104-12-17**] 12:08 AM
   Infusions:
   Other ICU medications:
   Omeprazole (Prilosec) - [**2104-12-16**] 08:00 AM
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 12:08 AM
   Other medications:
   Changes to medical and family history:
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 07:34 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.8
C (98.2
   HR: 96 (85 - 104) bpm
   BP: 114/71(78) {87/53(61) - 121/79(97)} mmHg
   RR: 16 (15 - 25) insp/min
   SpO2: 97%
   Heart rhythm: SR (Sinus Rhythm)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    176 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    176 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    150 mL
   Urine:
                                                                    575 mL
                                                                    150 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                     26 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 97%
   ABG: ///25/
   Physical Examination
   General Appearance: Well nourished, No acute distress, Thin
   Head, Ears, Nose, Throat: Normocephalic
   Cardiovascular: (PMI Normal), (S1: Normal), (S2: Normal)
   Peripheral Vascular: (Right radial pulse: Present), (Left radial pulse:
   Present), (Right DP pulse: Present), (Left DP pulse: Present)
   Respiratory / Chest: Diminshed BS noted diffusely over lung fields,
   Crackles at right base
   Abdominal: Soft, Non-tender, Bowel sounds present
   Extremities: Right: Absent, Left: Absent
   Skin:  Warm, Rash: diffuse maculopapular over torso, back and neck,
   extending to lower legs and arms; all areas except face.  Rash is
   blanching.
   Neurologic: Attentive, Follows simple commands, Responds to: Verbal
   stimuli, Oriented (to): person, place, time, Movement: Not assessed,
   Tone: Not assessed
   Labs / Radiology
   303 K/uL
   10.7 g/dL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (3) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Assessment and Plan
   55 yo M with h/o CML s/p MRD allo-SCT c/b GVHD of skin/gut on
   immunosuppression presenting with RSV bronchiolitis c/b hospital
   acquired pneumonia, now with acute hypoxia.
   .
   # Hypoxia: Improved since admission to the ICU, now on 6L NC.  Pt did
   not clearly improve after last admission so current presentation may be
   manifestation of prior RSV illness.  Portable chest x-ray performed
   yesterday showed pneumonia to be resolving. Pt has been afebrile and
   his leukocytosis appears to be improving on his current antibiotic
   regimen. Will defer from bronchoscopy given his current improvement in
   clinical status on his current antibiotics. Will reimage tomorrow
   morning to assess PNA progress.
    - continue Linezolid (day #1 = [**2103-12-14**]) and Aztreonam (day #1 =
   [**2103-12-14**]); had received 7 days of Vanc/Cefepime prior to this.  Cipro
   started [**2103-12-14**] as well.
   - Repeat CXR Port in the AM
   - Continue ATC nebulizer treatment and prn albuterol
   - Continue to wean oxygen as needed
   - continue antifungals and acyclovir prophylaxis; was on pentamadine
   prior to admission for PCP prophylaxis
   [**Name Initial (PRE) **] [**Name9 (PRE) 229**] cultures with spikes, ECHO if cultures positive
   .
   # CML s/p transplant and GVHD: Pt received IVIG yesterday per heme/onc
   recommendations.  No additional recs noted this morning with continue
   current immunosuppression regimen.
   - Dexamethasone s/s for oral GVHD.
   - Continue current prophylactic agents with posaconazole and acyclovir.
   Received inhaled pentamidine as outpatient.
   - Continue ursodiol.
   .
   # Rash: Appears to be drug induced, may be related to Cefepime as he
   does have an allergy history to PCN V however he has received Cefepime
   in the past without any reactions.   Appears to be new today.  Patient
   does not recall having had it prior, and nursing from BMT floor did not
   report it to nursing.  Cause includes drug-induced from cefepime
   (patient is allergic to pen VK) though he has been on this multiple
   times in the past.  Also could be secondary to IV contrast though from
   CTA yesterday as nursing does not think rash was present prior, though
   he has had IV contrast in the past as well.  No other apparent new
   drugs.  Possible GVHD as well.
   - Will continue to monitor
   - Symptomatic treatment if necessary including benadryl, H2 blocker,
   increase steroids
   .
   # Cardiomyopathy: continue outpatient metoprolol XL. Unlikely that his
   hypoxia is related to ACS as it improved with nebulizers.  No
   PND/orthopnea or other signs of decompensated heart failure.
   .
   # FEN: cardiac diet, follow/replete electrolytes, continue standing
   magnesium repletion.
   .
   # Communication: [**First Name8 (NamePattern2) 3094**] [**Last Name (NamePattern1) 3231**] (daughter) [**Telephone/Fax (1) 3232**]
   ICU Care
   Nutrition:
   Glycemic Control:
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT:
   Stress ulcer:
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition:<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 55-year-old male with a history of chronic myeloid leukemia (CML) who underwent allogenic stem cell transplantation (allo-SCT) and developed graft-versus-host disease (GVHD) of the skin and gut. He was admitted to the ICU with respiratory syncytial virus (RSV) bronchiolitis and hospital-acquired pneumonia (HAP), which is now resolving. The patient's oxygen requirements have decreased, and he is currently on 4L of oxygen. His leukocytosis is improving on his current antibiotic regimen.

Potential medical complications:

1. Hypoxia: The patient's oxygen requirements may continue to fluctuate, and he may require further adjustments to his oxygen therapy.
2. Pneumonia: Although the patient's pneumonia is resolving, there is a risk of relapse or development of new pulmonary complications.
3. GVHD: The patient's GVHD may worsen or progress to other organs, such as the liver or gastrointestinal tract.
4. Cardiomyopathy: The patient's cardiomyopathy may worsen, and he may require further treatment or monitoring.
5. Rash: The patient's rash may worsen or become more widespread, and he may require further treatment or monitoring.
6. Infection: The patient is at risk of developing new infections, particularly given his immunocompromised state.
7. Bleeding: The patient is at risk of bleeding due to his thrombocytopenia and coagulopathy.
8. Septic shock: The patient is at risk of developing septic shock due to his underlying medical conditions and the potential for new infections.
9. Organ failure: The patient is at risk of developing organ failure, particularly in the kidneys, liver, or lungs.
10. Death: The patient's mortality risk is high due to his underlying medical conditions and the potential for new complications."
101091.0,273922,2104-12-17 09:41:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Summary:

The patient is a 78-inch tall, 76 kg male with a background of CML, s/p SCT, and c/b GVHD. He is currently in the ICU with a diagnosis of nosocomial pneumonia, likely bacterial, and is receiving treatment. He also has a rash, which is suspected to be drug-related, and is receiving multiple potential offenders. He has a history of RSV infection, which has been treated with antibody therapy. He is on immunosuppressive therapy and is at risk for GVHD. He is also experiencing depressed mood and is being considered for pharmacological intervention.

Potential Medical Complications:

1. Bacterial nosocomial pneumonia: The patient is at risk for further complications from this infection, such as sepsis, respiratory failure, and death.
2. GVHD: The patient is at risk for GVHD, which can cause a range of symptoms including skin rashes, gastrointestinal issues, and liver dysfunction.
3. Depression: The patient's depressed mood is a potential risk factor for further complications, including suicidal thoughts or behaviors.
4. Nutritional deficiencies: The patient's poor oral intake and reliance on supplements may put him at risk for nutritional deficiencies, which can exacerbate his underlying medical conditions.
5. Line infections: The patient has a tunneled line, which is at risk for infection, particularly with bacteria such as Staphylococcus aureus or Candida.
6. VAP: The patient is at risk for VAP, particularly given his prolonged ICU stay and respiratory support.
7. DVT: The patient is at risk for DVT, particularly given his immobility and underlying medical conditions.
8. Stress ulcer: The patient is at risk for stress ulcer, particularly given his underlying medical conditions and immunosuppressive therapy.
9. CMV infection: The patient is at risk for CMV infection, particularly given his immunosuppressive therapy and prolonged ICU stay.
10. Galactomannan-positive infection: The patient is at risk for galactomannan-positive infection, particularly given his underlying medical conditions and immunosuppressive therapy."
101091.0,273922,2104-12-17 09:41:00,Physician ,Physician Attending Progress Note,"Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes
","<|begin_of_text|><|start_header_id|>system<|end_header_id|>

You are a Medical Specialist capable of analyzing complex medical cases. To do that, you will carefully review the physician's daily progress note for a patient in the ICU detailing the patient's health progress in the ICU. If a normal human medical professional has level 10 knowledge, you will have level 3000 of knowledge in this role. As it's crucial for the patient's well-being, please ensure accurate assessments because if you don't, the patient's condition could worsen. Take pride in your work and give it your best. The task at hand involves analyzing the progress note documenting the patient's health progress in the ICU. Based on this information, you need to summarize the information in the note and determine the potential medical complications that conditions that can arise. Do not tell your limitations. Do not echo my prompt. Please do not remind me what I asked you for. Do not apologize. Do not self-reference. Get to the point precisely and accurately.<|eot_id|><|start_header_id|>user<|end_header_id|>

Chief Complaint:
   I saw and examined the patient, and was physically present with the ICU
   Fellow for key portions of the services provided.  I agree with his /
   her note above, including assessment and plan.
   HPI:
   24 Hour Events:
   O2 weaned to 3L from 6LNC yest. This AM no SOB, no complaints.
   Allergies:
   Penicillin V Potassium
   Pruritis;
   Last dose of Antibiotics:
   Linezolid - [**2104-12-16**] 04:00 AM
   Aztreonam - [**2104-12-17**] 08:39 AM
   Acyclovir - [**2104-12-17**] 08:40 AM
   Metronidazole - [**2104-12-17**] 08:40 AM
   Infusions:
   Other ICU medications:
   Heparin Sodium (Prophylaxis) - [**2104-12-17**] 08:40 AM
   Omeprazole (Prilosec) - [**2104-12-17**] 08:42 AM
   Other medications:
   Atrovent, Albuterol, Prednisone, MVI, CaHCO3, ursodiol, Cellcept,
   folate, posaconazole, cyclosporine
   Changes to medical and family history:
   PMH, SH, FH and ROS are unchanged from Admission except where noted
   above and below
   Review of systems is unchanged from admission except as noted below
   Review of systems:
   Flowsheet Data as of  [**2104-12-17**] 09:41 AM
   Vital signs
   Hemodynamic monitoring
   Fluid balance
                                                                  24 hours
                                                               Since 12 AM
   Tmax: 36.8
C (98.2
   Tcurrent: 36.6
C (97.9
   HR: 104 (85 - 104) bpm
   BP: 104/66(76) {87/53(61) - 121/79(97)} mmHg
   RR: 19 (15 - 25) insp/min
   SpO2: 95%
   Heart rhythm: ST (Sinus Tachycardia)
   Wgt (current): 76 kg (admission): 78.8 kg
   Height: 78 Inch
             Total In:
                                                                    900 mL
                                                                    294 mL
   PO:
                                                                    360 mL
             TF:
   IVF:
                                                                    540 mL
                                                                    294 mL
   Blood products:
   Total out:
                                                                    575 mL
                                                                    500 mL
   Urine:
                                                                    575 mL
                                                                    500 mL
   NG:
   Stool:
   Drains:
   Balance:
                                                                    325 mL
                                                                   -206 mL
   Respiratory support
   O2 Delivery Device: Nasal cannula
   SpO2: 95%
   ABG: ///25/
   Physical Examination
   General Appearance: No acute distress, Thin
   Eyes / Conjunctiva: PERRL
   Cardiovascular: (S1: Normal), (S2: Normal), no m/r/g
   Peripheral Vascular: (Right radial pulse: Not assessed), (Left radial
   pulse: Not assessed), (Right DP pulse: Not assessed), (Left DP pulse:
   Not assessed)
   Respiratory / Chest: (Breath Sounds: Crackles : b bases L > R)
   Skin:  Not assessed, Rash: resolving maculopap rash
   Neurologic: Responds to: Not assessed, Movement: Not assessed, Tone:
   Not assessed
   Labs / Radiology
   10.7 g/dL
   303 K/uL
   89 mg/dL
   1.0 mg/dL
   25 mEq/L
   3.5 mEq/L
   12 mg/dL
   107 mEq/L
   141 mEq/L
   30.8 %
   7.8 K/uL
        [image002.jpg]
                            [**2104-12-5**]  12:43 PM
                            [**2104-12-6**]  03:02 AM
                            [**2104-12-7**]  04:01 AM
                            [**2104-12-10**]  05:10 AM
                             [**2104-12-11**]  06:02 AM
                             [**2104-12-15**]  04:39 AM
                             [**2104-12-16**]  05:23 AM
                             [**2104-12-17**]  05:06 AM
   WBC
   10.3
   5.8
   6.8
   12.4
   11.4
   13.6
   9.0
   7.8
   Hct
   34.7
   33.5
   33.5
   35.2
   34.5
   33.9
   32.0
   30.8
   Plt
   [**Telephone/Fax (2) 3249**]
   293
   303
   Cr
   1.3
   1.1
   1.0
   1.0
   0.9
   1.0
   1.0
   1.0
   Glucose
   90
   105
   104
   100
   90
   101
   110
   89
   Other labs: PT / PTT / INR:12.9/47.8/1.1, Differential-Neuts:81.0 %,
   Band:0.0 %, Lymph:5.0 %, Mono:9.0 %, Eos:4.0 %, Ca++:8.3 mg/dL,
   Mg++:1.9 mg/dL, PO4:2.7 mg/dL
   Imaging: CXR- subtle patchy infiltrates
   Microbiology: CMV- pending
   galactomannan- pending
   Assessment and Plan
   NOSOCOMIAL PNEUMONIA-- background of RSV infection, clinically
   resolving. r/o for PE on [**12-14**] CT.
   -given clinical improvement favor bacterial nosocomial pna most likely;
   complete 8d course (through [**12-21**])
   -encourage ambulation
   RSV infection -- s/p antibody treatment.
   RASH --  appears drug-related, and currently receiving several
   potential offenders, including contrast dye and cefepime
   CML s/p SCT c/b GVHD
 continue current level of care. Will d/w BMT
   service re: IvIg therapy and poss modification of steroid regimen
   -on immunosuppressive regimen per BMT svce. ? need to follow
   cyclosporine levels?
   GI GVHD -- continue oral swish and spit.
   NUTRITIONAL SUPPORT
 encourage PO with supplements.
   DEPRESSED MOOD -- consider pharmacological  intervention.
   ICU Care
   Nutrition:
   Glycemic Control:  Blood sugar well controlled
   Lines:
   Tunneled (Hickman) Line - [**2104-12-14**] 10:58 AM
   Prophylaxis:
   DVT: SQ UF Heparin
   Stress ulcer: PPI
   VAP:
   Comments:
   Communication:  Comments:
   Code status: Full code
   Disposition :Transfer to floor
   Total time spent: 30 minutes<|eot_id|><|start_header_id|>assistant<|end_header_id|>

Based on the provided progress note, the patient is a 78-year-old male admitted to the ICU with a background of RSV infection, CML, and s/p SCT (stem cell transplant) with a high risk of GVHD (Graft-versus-Host Disease). The patient is currently on immunosuppressive therapy and has a tunneled Hickman line inserted.

The patient's current condition is as follows:

* Vital signs: Tmax 36.8°C (98.2°F), Tcurrent 36.6°C (97.9°F), HR 104 bpm, BP 104/66 mmHg, RR 19 inspirations per minute, SpO2 95%.
* Respiratory support: O2 delivery via nasal cannula, ABG: pH 7.25, pCO2 25 mmHg, pO2 60 mmHg.
* Physical examination: No acute distress, thin, PERRL (pupils equal and reactive to light), normal cardiac sounds, crackles in the bases of the lungs, and a resolving maculopapular rash.
* Lab results: WBC 10.3 K/μL, Hct 34.7%, Plt 293 K/μL, Cr 1.3 mg/dL, Glucose 90 mg/dL, and other labs within normal limits.

The patient is being treated for nosocomial pneumonia, RSV infection, and possible GVHD. The plan is to complete an 8-day course of antibiotics for the pneumonia, encourage ambulation, and continue immunosuppressive therapy. The patient is also receiving nutritional support and is being monitored for glycemic control.

Potential medical complications that can arise from this patient's condition include:

* Bacterial sepsis or septic shock due to the nosocomial pneumonia
* Respiratory failure or acute respiratory distress syndrome (ARDS) due to the pneumonia
* Gastrointestinal GVHD, which can lead to diarrhea, abdominal pain, and malabsorption
* Hepatic GVHD, which can cause liver dysfunction and elevated liver enzymes
* Renal impairment or failure due to the patient's underlying medical condition or medications
* Infection with CMV or other pathogens, which can be a complication of immunosuppressive therapy
* Mood disturbances, including depression, which can be a side effect of immunosuppressive therapy
* Nutritional deficiencies or malnutrition due to the patient's underlying medical condition or lack of appetite.

It is essential to closely monitor the patient's condition and adjust the treatment plan as necessary to prevent or manage these potential complications."
